Table 1.
Clinical demographics | PD (n = 55) | Control (n = 37) | P |
---|---|---|---|
Age (year) (mean ± SD) | 59.9 ± 10.9 | 62.9 ± 6.3 | 0.136 |
Sex (M, F) | 22, 33 | 18, 19 | 0.089 |
White blood cells (×103/mL)# | 5.60 (5.00, 6.80) | 6.05 (4.88, 8.43) | 0.250 |
Red blood cells (×104/mL)# | 4.78 (4.42, 5.08) | 4.41 (4.09, 5.00) | 0.410 |
Platelet counts (×104/mL)# | 232 (200, 306) | 223 (173, 276) | 0.156 |
Duration of disease (years)# | 2.5 (1.0, 5.5) | ||
UPDRS I# | 3.0 (1.0, 6.0) | ||
UPDRS II# | 10.0 (4.0, 16.0) | ||
UPDRS III# | 22.0 (14.0, 34.0) | ||
UPDRS total# | 33.0 (20.0, 54.0) | ||
Modified H & Y# (maximum stage is 5) | 1.75 (1.0, 3.0) | ||
S & E# (minimum point is 0 suggesting vegetative functions) | 90.0 (77.5, 100.0) | ||
TRODATE R# | 1.45 (1.24, 1.62) | ||
TRODATE L# | 1.37 (1.23, 1.53) |
UPDRS: Unified Parkinson's Disease Rating Scale; modified H & Y: modified Hoehn and Yahr Staging Scale; S & E: Schwab and England Activities of Daily Living Scale.
#Median (IQR): IQR: interquartile range.